Cancel
Jim Carr
Chief Clinical Development Officer
@
Stealth BioTherapeutics
k3n.fpuz@uk869g29p.ufp
Sign up to see email
Known information
- Has over 20 years of industry experience in clinical development, medical affairs, lifecycle management, new product planning, and global marketing.
- Previously served as an Executive Director in the Global Cardiovascular Franchise at GlaxoSmithKline.
- Held the role of Vice President of Clinical Development at Arca Biopharma.
- Holds a Doctor of Pharmacy degree from the University of Minnesota.
- Completed post-graduate training in clinical cardiovascular pharmacology.
- Was on the clinical faculty at the University at Buffalo-SUNY School of Pharmacy.
About Stealth BioTherapeutics
Stealth BioTherapeutics develops therapies for mitochondrial dysfunction related to genetic diseases and aging, with a focus on elamipretide and SBT-272 in clinical studies.
Report inaccurate information
